Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001104659-21-033301

Options or other derivatives

  • Director acquired 7,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
SCHEINBERG DAVID A Director 2021-03-04 Grant or award · Stock Option (Right to Buy) +7,500 7,500 D
Loading xslF345X03/tm218923d7_4.xml…